Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Scott Miners

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Neurochemistry|February 8, 2017
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodiesJames Scott Miners, Seth Love
Brain Pathology (Zurich, Switzerland)|March 9, 2011
Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cellsJames Scott Miners, Patrick Kehoe, Seth Love
Journal of Alzheimer'S Disease : JAD|February 8, 2014
Differential changes in Aβ42 and Aβ40 with ageJames Scott Miners, Ruth Jones, Seth Love
Journal of Neuroscience Methods|January 29, 2008
Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenatesJames Scott Miners, Patrick Gavin Kehoe, Seth Love
Journal of Alzheimer'S Disease : JAD|December 12, 2017
VEGFR1 and VEGFR2 in Alzheimer's DiseaseRachel Harris, James Scott Miners, Shelley Allen, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activitiesJames Scott Miners, Sean Morris, Seth Love, et al.
Journal of Neuropathology and Experimental Neurology|October 18, 2011
Aβ-degrading enzymes: potential for treatment of Alzheimer diseaseJames Scott Miners, Neil Barua, Patrick Gavin Kehoe, et al.
Journal of Neuropathology and Experimental Neurology|July 17, 2009
Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severityJames Scott Miners, Shabnam Baig, Hannah Tayler, et al.
Journal of Neuroscience Methods|October 2, 2007
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluidJames Scott Miners, Marcel M Verbeek, Marcel Olde Rikkert, et al.
Brain Pathology (Zurich, Switzerland)|March 28, 2008
Abeta-degrading enzymes in Alzheimer's diseaseJames Scott Miners, Shabnam Baig, Jennifer Palmer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|February 8, 2017
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodiesJames Scott Miners, Seth Love
Brain Pathology (Zurich, Switzerland)|March 9, 2011
Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cellsJames Scott Miners, Patrick Kehoe, Seth Love
Journal of Alzheimer'S Disease : JAD|February 8, 2014
Differential changes in Aβ42 and Aβ40 with ageJames Scott Miners, Ruth Jones, Seth Love
Journal of Neuroscience Methods|January 29, 2008
Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenatesJames Scott Miners, Patrick Gavin Kehoe, Seth Love
Journal of Alzheimer'S Disease : JAD|December 12, 2017
VEGFR1 and VEGFR2 in Alzheimer's DiseaseRachel Harris, James Scott Miners, Shelley Allen, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activitiesJames Scott Miners, Sean Morris, Seth Love, et al.
Journal of Neuropathology and Experimental Neurology|October 18, 2011
Aβ-degrading enzymes: potential for treatment of Alzheimer diseaseJames Scott Miners, Neil Barua, Patrick Gavin Kehoe, et al.
Journal of Neuropathology and Experimental Neurology|July 17, 2009
Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severityJames Scott Miners, Shabnam Baig, Hannah Tayler, et al.
Journal of Neuroscience Methods|October 2, 2007
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluidJames Scott Miners, Marcel M Verbeek, Marcel Olde Rikkert, et al.
Brain Pathology (Zurich, Switzerland)|March 28, 2008
Abeta-degrading enzymes in Alzheimer's diseaseJames Scott Miners, Shabnam Baig, Jennifer Palmer, et al.
Pageof 2